Monte Rosa Therapeutics
GLUE
#7469
Rank
HK$2.43 B
Marketcap
HK$38.40
Share price
-2.17%
Change (1 day)
-12.57%
Change (1 year)

EPS for Monte Rosa Therapeutics (GLUE)

EPS in 2023 (TTM): -HK$20.14

According to Monte Rosa Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$19.94. In 2022 the company made an earnings per share (EPS) of -HK$17.76 an increase over its 2021 EPS that were of -HK$37.64.

EPS history for Monte Rosa Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$20.1413.4%
2022-HK$17.76-52.81%
2021-HK$37.64193.97%
2020-HK$12.80